Industry

MUNICH, Germany–(BUSINESS WIRE)–CatalYm today announced that it has received Investigational New Drug (IND) clearance from the United States Food and Drug Administration (FDA) to expand its ongoing Phase 2 clinical program to include clinical trial centers in the U.S. The ongoing GDFATHER-2 program (GDF-15-neutralizing antibody-mediated human effector cell relocation) is evaluating the company’s lead candidate, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Middle East and Africa Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product and Application” report has been added to ResearchAndMarkets.com’s offering. The travel vaccines market in MEA is expected to grow from US$ 120.13 million in 2021 to US$ 167.76 million by 2028; it is estimated to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Pernicious Anemia Market Research and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global pernicious anemia diagnosis and treatment market is anticipated to grow at a significant CAGR of 7.1% during the forecast period. Pernicious anemia is a disease in which the formation of red blood cells becomes slow due … [Read more…]

HELSINKI–(BUSINESS WIRE)–TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, announces it has signed a second clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, for a new clinical trial evaluating TILT-123, its oncolytic adenovirus armed with two human cytokines, in combination with KEYTRUDA® (pembrolizumab), MSD’s … [Read more…]

CARDIFF, Wales–(BUSINESS WIRE)–Singular Talent: Specific research on the world of work in Biotech is hard to find. Singular Talent decided to fix this. This Autumn sees two drops of primary data about working in Biotech. Insight from nearly 1,000 interviews and a further deep dive survey. Interviews over the last year reveal key trends that … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the participation of Sensorion’s management in various upcoming investor conferences. CEO Nawal Ouzren will attend, in-person, the Jefferies Cell and Genetic … [Read more…]

In a Los Angeles Times ad set to run Sunday, September 25th, AHF continues its plea to California Governor Gavin Newsom to help prevent the interruption of care for over 1,400 AIDS patients in Los Angeles LOS ANGELES–(BUSINESS WIRE)–AHF will run a full-page, full-color advocacy ad in the Los Angeles Times this Sunday, September 25th. … [Read more…]

Healthcare Agency Assigns Kristi Onkka Unique Engagement Role IRVINE, Calif.–(BUSINESS WIRE)–QooQoo, a growing independent healthcare marketing agency, has named Kristi Hansen Onkka as Chief Engagement Officer. Her leadership responsibilities include improving engagement across both client and agency initiatives. QooQoo created the position to elevate innovation across customer-facing engagement channels, including brand managers, healthcare professionals, and … [Read more…]

DOVER, Del.–(BUSINESS WIRE)–Mana Capital Acquisition Corp. (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR) (the “Company” or “Mana Capital”), a special purpose acquisition company (“Mana Capital”), announced today that for the purpose of consummating its previously announced business combination with Cardio Diagnostics, Inc. (“Cardio”), the Company has further extended the date by which it is required to complete … [Read more…]

ROCHESTER HILLS, Mich.–(BUSINESS WIRE)–InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today the appointment of R. Rimmy Malhotra, a new independent director to InfuSystem’s Board of Directors, effective September 20, 2022. Mr. Malhotra … [Read more…]